Moxetumomab

Tax included
Moxetumomab, a recombinant CD22-targeting immunotoxin, can be used for the research of hairy cell leukemia (HCL).
MedChemExpress 
HY-P99034

Data sheet

Size
Multiple sizes
Reactivity
ADC Antibody; CD22
Application
COVID-19-immunoregulation
CAS
1622075-65-3